Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?

Alonso Marquez, Daniel Batlle*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

In this commentary we emphasize the renoprotective effect of cyclic angiotensin-(1-7) described by Cassis et al. in a mouse model of diabetic kidney disease. The importance of the study is that this peptide was even more protective than the angiotensin-converting enzyme inhibitor lisinopril administered alone and that when the 2 componds were combined, the renoprotective action was additive.

Original languageEnglish (US)
Pages (from-to)815-817
Number of pages3
JournalKidney international
Volume96
Issue number4
DOIs
StatePublished - Oct 2019

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?'. Together they form a unique fingerprint.

Cite this